| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.43 | 2e-29 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-21 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-18 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-16 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-15 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-15 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.23 | 8e-14 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-13 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-13 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-12 |